Prevention of heart failure - A clinical reality?

被引:0
作者
Lee, W [1 ]
Arnold, JMO [1 ]
机构
[1] Univ Western Ontario, Dept Med, Div Cardiol, London Hlth Sci Ctr, London, ON N6A 4G5, Canada
来源
FRONTIERS IN CARDIOVASCULAR HEALTH | 2003年 / 9卷
关键词
heart failure; risk factors; hypertension; angiotensin converting enzyme inhibitors; beta-adrenoceptor blockers;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart failure is a major public health problem and has substantial economic impact. Over the past several decades, the mortality for most cardiovascular diseases has declined. In contrast, the incidence of and mortality for heart failure have increased. The key steps to approach an epidemic are prevention and early intervention. Effective prevention of heart failure can be achieved by modification of risk factors, aggressive management of coronary heart disease and hypertension, and early treatment of left ventricular dysfunction.
引用
收藏
页码:549 / 561
页数:13
相关论文
共 48 条
  • [1] AMERY A, 1985, LANCET, V1, P1349
  • [2] [Anonymous], 1991, JAMA, V265, P3255
  • [3] BALL SG, 1993, LANCET, V342, P821
  • [4] *BET BLOCK HEART A, 1982, JAMA-J AM MED ASSOC, V250, P2814
  • [5] ACC/AHA guidelines for the management of patients with valvular heart disease - A report of the American College of Cardiology American Heart Association Task Force on practice guidelines (Committee on Management of Patients with Valvular Heart Disease)
    Bonow, RO
    Carabello, B
    De Leon, AC
    Edmunds, LH
    Fedderly, BJ
    Freed, MD
    Gaasch, WH
    Mckay, CR
    Nishimura, RA
    O'Gara, PT
    O'Rourke, RA
    Rahimtoola, SH
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (05) : 1486 - 1582
  • [6] COLLINS R, 1995, LANCET, V345, P669
  • [7] RANDOMIZED TRIAL OF TREATMENT OF HYPERTENSION IN ELDERLY PATIENTS IN PRIMARY CARE
    COOPE, J
    WARRENDER, TS
    [J]. BRITISH MEDICAL JOURNAL, 1986, 293 (6555) : 1145 - 1151
  • [8] MORBIDITY AND MORTALITY IN THE SWEDISH TRIAL IN OLD PATIENTS WITH HYPERTENSION (STOP-HYPERTENSION)
    DAHLOF, B
    LINDHOLM, LH
    HANSSON, L
    SCHERSTEN, B
    EKBOM, T
    WESTER, PO
    [J]. LANCET, 1991, 338 (8778) : 1281 - 1285
  • [9] Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial
    Dargie, HJ
    Colucci, Y
    Ford, I
    Sendon, JLL
    Remme, W
    Sharpe, N
    Blank, A
    Holcslaw, TL
    [J]. LANCET, 2001, 357 (9266) : 1385 - 1390
  • [10] DEVITA C, 1994, LANCET, V343, P1115